Latest Coronavirus Disease COVID 19 News and Research
Republican Convention, Day 4: Fireworks … and shining a light on Trump’s claims
President Donald Trump accepted the Republican Party's nomination for president in a 70-minute speech from the South Lawn of the White House on Thursday night.
COVID + influenza: This is a good year to get a flu shot, experts advise
Flu season will look different this year, as the country grapples with a coronavirus pandemic that has killed more than 172,000 people. Many Americans are reluctant to visit a doctor's office and public health officials worry people will shy away from being immunized.
New cellular pathway protects cells from infection by Ebola virus, coronaviruses
Discoveries from the Benaroya Research Institute at Virginia Mason (BRI) have identified a new cellular protection pathway that targets a common vulnerability in several different pandemic viruses, and collaborators at Case Western Reserve University, Boston University School of Medicine and MRIGlobal have shown that this pathway can protect cells from infection by Ebola virus and coronaviruses, like SARS-CoV-2.
FDA continues to take action in the ongoing response to COVID-19 pandemic
The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic
COVID-19 can serve as catalyst for digital innovation in healthcare
COVID-19 has upended essentially every sector of the economy, and none more so than healthcare. Healthcare leaders from across the United States share their experiences with disruption and innovation in responding to the COVID-19 crisis in the Fall 2020 issue of Frontiers of Health Services Management, a publication of the American College of Healthcare Executives (ACHE).
FDA grants Abbott's COVID-19 rapid antigen test gets emergency-use authorization
Now, the U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response COVID-19 antigen test, called BinaxNOW COVID-19 Ag Card, which is roughly the size of a credit card.
Blood thinners help reduce the risk of COVID-19 deaths, study finds
Now, a new study by a team of researchers at the Mount Sinai Health System in New York has shown that blood thinners may reduce the risk of death by up to 50 percent among severely ill hospitalized COVID-19 patients.
New low-cost COVID-19 test quickly delivers accurate results
A new low-cost diagnostic test for coronavirus disease 2019 (COVID-19) quickly delivers accurate results without the need for sophisticated equipment, according to a study published August 27 2020 in the open-access journal PLOS Pathogens by Teng Xu of the Vision Medicals Center for Infectious Diseases, Tieying Hou of the Guangdong Academy of Medical Sciences, Bing Gu of the Affiliated Hospital of Xuzhou Medical University, Jianwei Wang of the Chinese Academy of Medical Sciences and Peking Union Medical College, and colleagues.
SARS discovery boots search for COVID-19 drugs
An extensive search and testing of current drugs and drug-like compounds has revealed compounds previously developed to fight SARS might also work against COVID-19.
Mouse-adapted SARS-CoV-2 model helps advance the development of COVID-19 vaccines
A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.
Study shows furin cleavage site is crucial for SARS-CoV-2 replication
In a recent bioRxiv* preprint paper, researchers from the United States demonstrate the pivotal role the furin cleavage site insertion in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein plays in viral replication and pathogenesis – highlighting, in turn, the need for mutation monitoring when developing therapeutics and vaccines.
Evidence of SARS-CoV-2 coronavirus particles in heart tissue
Researchers in Milan, Italy, have identified the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the heart tissue of deceased coronavirus disease 2019 (COVID-19) patients who had died from respiratory failure, without showing any signs of cardiac involvement.
Study: Estrogen may reduce severity of COVID-19 symptoms in women
Why are men at greater risk than women for more severe symptoms and worse outcomes from COVID-19 regardless of age?
Two viral gene targets needed in SARS-CoV-2 detection by PCR, say researchers
Researchers at the Chan Zuckerberg Biohub, San Francisco, and collaborators have warned against only targeting one viral gene when carrying out reverse transcriptase-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
First lethal mouse model of SARS-CoV-2 developed
Army scientists have developed the first lethal mouse model of SARS-CoV-2, the virus that causes COVID-19, using mice that were genetically engineered to express the human ACE2 gene--a key mechanism by which the virus enters human cells.
NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases
The National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, today announced that it has awarded 11 grants with a total first-year value of approximately $17 million to establish the Centers for Research in Emerging Infectious Diseases.
Pence praises Trump’s ‘seamless’ COVID response, leaves out his state feuds
Vice President Mike Pence portrayed his boss, President Donald Trump, as a leader who has reached out across the aisle to help during the coronavirus pandemic.
FDA warns consumers about alcohol-based hand sanitizers packaged in containers
The U.S. Food and Drug Administration (FDA) is warning consumers about alcohol-based hand sanitizers that are being packaged in containers that may appear as food or drinks and may put consumers at risk of serious injury or death if ingested.
Scientists say insect repellent kills the SARS-CoV-2 coronavirus on surfaces
Now, a team of scientists at Britain's Defence Science and Technology Laboratory (DSTL) has shared preliminary findings of their research, showing that a product in insect repellent can kill the SARS-CoV-2 virus.
Voters' education accounts for largest divide among respondents, show poll results
Incumbent Edward Markey has opened up a double-digit lead over challenger U.S. Rep. Joseph Kennedy III one week before the Democratic primary in the race for U.S. Senate, according to a new poll of Massachusetts voters released today.
.png)
No hay comentarios:
Publicar un comentario